Adicet Bio, Inc. — Director's Dealing 2020

Sep 18, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-09-15

Reporting Person: OrbiMed Capital GP V LLC (Director)
Reporting Person: OrbiMed Advisors Israel II Ltd (Director)
Reporting Person: OrbiMed Israel GP II, L.P. (Director)
Reporting Person: OrbiMed Israel GP Ltd. (Director)
Reporting Person: OrbiMed Israel BioFund GP Limited Partnership (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Indirect

Footnotes

F1: This report is being jointly filed by OrbiMed Capital GP V LLC, OrbiMed Israel BioFund GP Limited, OrbiMed Israel GP Ltd., OrbiMed Israel Partners II, L.P., and OrbiMed Israel GP II, L.P. The Reporting Persons have designated Carl L. Gordon ("Gordon") and Erez Chimovits ("Chimovits") to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons, Gordon, or Chimovits is a beneficial owner of the Issuer's securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.